Lung cancer and pleural mesothelioma are often confused, so it’s important to understand the key differences between them, including tumor location and treatments. Lung cancer and pleural mesothelioma ...

The combination statistically significantly improved overall survival, reducing the risk of death by 21% compared with chemotherapy alone. The Food and Drug Administration (FDA) has approved Keytruda ...

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...

Malignant pleural mesothelioma (MPM) is a primary and locally aggressive tumor of the pleura. A well defined causal relationship with asbestos exposure, and an overwhelming media interest in the use ...

First-line chemotherapy plus an investigational arginine-depleting agent improved survival in nonepithelioid pleural mesothelioma compared with chemotherapy alone, a randomized trial showed. For the ...

Future Oncol. 2009;5(3):391-402. 1 Laboratory of Molecular Oncology, Clinic and Policlinic of Oncology, University Hosptial, CH-8091 Zürich, Switzerland. 2 Division of Thoracic Surgery, University ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to chemotherapy significantly extended OS as first-line therapy for advanced ...

The approval was based on a pre-specified interim analysis from the open-label phase 3 CheckMate -743 trial. The Food and Drug Administration (FDA) has approved Opdivo® (nivolumab; Bristol Myers ...

Heather Von St James was diagnosed with pleural mesothelioma at the age of 36 after being exposed to asbestos as a child ...

To date, there is no standard therapy for malignant pleural mesothelioma. Historically, surgery is potentially beneficial in patients with low-volume disease, but in patients for whom surgery is not ...